Viewing Study NCT06009003


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2025-12-28 @ 5:30 PM
Study NCT ID: NCT06009003
Status: TEMPORARILY_NOT_AVAILABLE
Last Update Posted: 2024-08-06
First Post: 2023-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Individual Patient Esmethadone (REL-1017) Expanded Access Program
Sponsor: Relmada Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module